178 related articles for article (PubMed ID: 16176166)
1. Apolipoprotein A5 and triglyceridemia. Focus on the effects of the common variants.
Hubacek JA
Clin Chem Lab Med; 2005; 43(9):897-902. PubMed ID: 16176166
[TBL] [Abstract][Full Text] [Related]
2. Is apolipoprotein A5 a novel regulator of triglyceride-rich lipoproteins?
Jakel H; Nowak M; Helleboid-Chapman A; Fruchart-Najib J; Fruchart JC
Ann Med; 2006; 38(1):2-10. PubMed ID: 16448983
[TBL] [Abstract][Full Text] [Related]
3. [Apolipoprotein AV and triglyceridemia].
Hubácek JA
Cas Lek Cesk; 2004; 143(12):799-803. PubMed ID: 15730209
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein A5, a newly identified gene that affects plasma triglyceride levels in humans and mice.
Pennacchio LA; Rubin EM
Arterioscler Thromb Vasc Biol; 2003 Apr; 23(4):529-34. PubMed ID: 12615678
[TBL] [Abstract][Full Text] [Related]
5. [Apolipoprotein A5 gene: association with triglyceride metabolism and cardiovascular disease].
Oliveira Sousa M; Alía P; Pintó X
Med Clin (Barc); 2008 May; 130(20):787-93. PubMed ID: 18579034
[TBL] [Abstract][Full Text] [Related]
6. [A novel gene in APOA1/C3/A4/A5 cluster: apolipoprotein A5].
Liu HK; Zhang SZ; Su ZG; Ma YX; Wang CT
Yi Chuan; 2004 Nov; 26(6):953-6. PubMed ID: 15640132
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein A5 in health and disease.
Hubáček JA; Adámková V; Vrablík M; Kadlecová M; Zicha J; Kunes J; Pitha J; Suchánek P; Poledne R
Physiol Res; 2009; 58 Suppl 2():S101-S110. PubMed ID: 20131928
[TBL] [Abstract][Full Text] [Related]
8. Association of the APOLIPOPROTEIN A1/C3/A4/A5 gene cluster with triglyceride levels and LDL particle size in familial combined hyperlipidemia.
Mar R; Pajukanta P; Allayee H; Groenendijk M; Dallinga-Thie G; Krauss RM; Sinsheimer JS; Cantor RM; de Bruin TW; Lusis AJ
Circ Res; 2004 Apr; 94(7):993-9. PubMed ID: 15001527
[TBL] [Abstract][Full Text] [Related]
9. Analysis of apolipoprotein A5, c3, and plasma triglyceride concentrations in genetically engineered mice.
Baroukh N; Bauge E; Akiyama J; Chang J; Afzal V; Fruchart JC; Rubin EM; Fruchart-Najib J; Pennacchio LA
Arterioscler Thromb Vasc Biol; 2004 Jul; 24(7):1297-302. PubMed ID: 15117734
[TBL] [Abstract][Full Text] [Related]
10. APOA1/C3/A5 haplotype and risk of hypertriglyceridemia in Taiwanese.
Chien KL; Fang WH; Wen HC; Lin HP; Lin YL; Lin SW; Wu JH; Kao JT
Clin Chim Acta; 2008 Apr; 390(1-2):56-62. PubMed ID: 18206649
[TBL] [Abstract][Full Text] [Related]
11. The -1131 T>C and S19W APOA5 gene polymorphisms are associated with high levels of triglycerides and apolipoprotein C-III, but not with coronary artery disease: an angiographic study.
Martinelli N; Trabetti E; Bassi A; Girelli D; Friso S; Pizzolo F; Sandri M; Malerba G; Pignatti PF; Corrocher R; Olivieri O
Atherosclerosis; 2007 Apr; 191(2):409-17. PubMed ID: 16682041
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenetic association of the APOA1/C3/A4/A5 gene cluster and lipid responses to fenofibrate: the genetics of lipid-lowering drugs and diet network study.
Liu Y; Ordovas JM; Gao G; Province M; Straka RJ; Tsai MY; Lai CQ; Zhang K; Borecki I; Hixson JE; Allison DB; Arnett DK
Pharmacogenet Genomics; 2009 Feb; 19(2):161-9. PubMed ID: 19057464
[TBL] [Abstract][Full Text] [Related]
13. The role and mode of action of apolipoproteins CIII and AV: synergistic actors in triglyceride metabolism?
van Dijk KW; Rensen PC; Voshol PJ; Havekes LM
Curr Opin Lipidol; 2004 Jun; 15(3):239-46. PubMed ID: 15166778
[TBL] [Abstract][Full Text] [Related]
14. Associations of the apolipoprotein A1/C3/A4/A5 gene cluster with triglyceride and HDL cholesterol levels in women with type 2 diabetes.
Qi L; Liu S; Rifai N; Hunter D; Hu FB
Atherosclerosis; 2007 May; 192(1):204-10. PubMed ID: 16781717
[TBL] [Abstract][Full Text] [Related]
15. Impact of APOA5/A4/C3 genetic polymorphisms on lipid variables and cardiovascular disease risk in French men.
Dallongeville J; Cottel D; Montaye M; Codron V; Amouyel P; Helbecque N
Int J Cardiol; 2006 Jan; 106(2):152-6. PubMed ID: 16321685
[TBL] [Abstract][Full Text] [Related]
16. SNPs at the APOA5 gene account for the strong association with hypertriglyceridaemia at the APOA5/A4/C3/A1 locus on chromosome 11q23 in the Northern Irish population.
Wright WT; Young IS; Nicholls DP; Patterson C; Lyttle K; Graham CA
Atherosclerosis; 2006 Apr; 185(2):353-60. PubMed ID: 16125709
[TBL] [Abstract][Full Text] [Related]
17. APOA5 Ala315>Val, identified in patients with severe hypertriglyceridemia, is a common mutation with no major effects on plasma lipid levels.
Hubacek JA; Wang WW; Skodová Z; Adámková V; Vráblík M; Horínek A; Stulc T; Ceska R; Talmud PJ
Clin Chem Lab Med; 2008; 46(6):773-7. PubMed ID: 18601597
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein A-V deficiency results in marked hypertriglyceridemia attributable to decreased lipolysis of triglyceride-rich lipoproteins and removal of their remnants.
Grosskopf I; Baroukh N; Lee SJ; Kamari Y; Harats D; Rubin EM; Pennacchio LA; Cooper AD
Arterioscler Thromb Vasc Biol; 2005 Dec; 25(12):2573-9. PubMed ID: 16166565
[TBL] [Abstract][Full Text] [Related]
19. Rs964184 (APOA5-A4-C3-A1) is related to elevated plasma triglyceride levels, but not to an increased risk for vascular events in patients with clinically manifest vascular disease.
van de Woestijne AP; van der Graaf Y; de Bakker PI; Asselbergs FW; Spiering W; Visseren FL;
PLoS One; 2014; 9(6):e101082. PubMed ID: 24979386
[TBL] [Abstract][Full Text] [Related]
20. Resequencing the apolipoprotein A5 (APOA5) gene in patients with various forms of hypertriglyceridemia.
Evans D; Aberle J; Beil FU
Atherosclerosis; 2011 Dec; 219(2):715-20. PubMed ID: 21993410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]